214
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Development of thiolated poly(acrylic acid) microparticles for the nasal administration of exenatide

, , , , , & show all
Pages 1677-1682 | Received 27 Mar 2013, Accepted 05 Sep 2013, Published online: 16 Oct 2013

References

  • Butler AE, Janson J, Bonner-Weir J, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes miellitus. Diabetes 2003;52:102–10
  • Robles GI, Singh-Franco D. A review of exenatide as adjunctive theraphy in patients with type 2 diabetes. Drug Des Dev Ther 2009;3:219–40
  • Mustata G, Dihn SM. Approaches to oral drug delivery for challenging molecules. CRC Crit Rev Ther Drug Carr Sys 2006;23:1111–35
  • Khafagy ES, Morishita M, Onuki Y, Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Delivery Rev 2007;59:1521–46
  • Ozsoy Y, Gunor S, Cevher E. Nasal delivery of high moleular weight drugs. Molecules 2009;14:3754–90
  • Leitner VM, Guggi D, Bernkop-Schnurch A. Thiomers in noninvasive polypeptide delivery: in vitro and in vivo characterization of a polycarbophil-cysteine/glutathione gel formulation for human growth hormone. J Pharm Sci 2004;93:1682–91
  • Illum L. Nasal drug delivery: possibilities, problems and solutions. J Control Rel 2003;87:187–98
  • Bernkop-Schnürch A, Steininger S. Synthesis ans characterization of mucoadhesive thiolated polymers. Int J Pharm 2000;194:239–47
  • Clausen A, Bernkop-Schnürch A. In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. J Pharm Sci 2000;89:1253–61
  • Marschütz MK, Bernkop-Schnürch A. Thiolated polymers: self-crosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. Eur J Pharm Biopharm 2002;15:387–94
  • Bernkop-Schnürch A, Schwarz V, Steininger S. Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm Res 1999;16:876–81
  • Leitner VM, Walker GF, Bernkop-Schnurch A. Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. Eur J Pharm Biopharm 2003;56:207–14
  • Behl CR, Pimplaskar HK, Sileno AP, Romeo VD. Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Delivery Rev 1998;29:89–116
  • Glorieux S, Van der Broeck W, van der Meulenm SM, et al. In vitro culture of porcine respiratory mucosa explants for studying the interaction of porcine viruses with the respiratotory tract. J Virol Methods 2007;142:105–12
  • Schmidt MC, Simmen D, Hilbe M, et al. Validation of excised bovine nasal mucosa as in vitro model to study drug transport andmetabolic pathways in nasal epithelium. J Pharm Sci 2000;89:396–407
  • Toskala E, Haataja J, Shirasaki H, Rautiainen M. Culture of cells harvested with nasal brushing: a method for evaluating ciliary function. Rhinology 2005;29:17–26
  • Dimova S. High speed digital imaging method for ciliary beat frequency measurement. J Pharm Pharmacol 2005;57:1–6
  • Ugwoke MI, Agu RU, Jorissen M. Nasal toxicological investigations of Carbopol® 971P formulation of apomorphine: effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa. Eur J Pharm Biopharm 2000;9:387–96
  • Merkus P, Romeijn SG, Verhoef JC, et al. Classification of cilio-inhibitinf effects of nasal drugs. Laryngoscope 2001;111:595–602
  • Sanders P, Washington N, Frier M, et al. The deposition of solution-based and suspension-based aerosols from metered dose inhalers in healthy subjects and asmathic patients. STP Pharm Sci 1997;7:300–6
  • Jones N. The nose and paranasal sinuses physiology and anatomy. Adv Drug Delivery Rev 2001;51:5–19
  • Marttin E, Nicolaas GM, Schipper NGM, Coos Verhoef J. Nasal mucociliary clearance as a factor in nasal drug delivery. Adv Drug Delivery Rev 1998;29:13–38
  • Arora P, Sharma S, Garg S. Permeability issues in nasal drug delivery. Drug Discov Today 2002;7:967–75
  • Deutel B, Greindl M, Thaurer M, Bernkop-Schnürch A. Novel insulin thiomer nanoparticles: in vivo evaluation of an oral drug delievry system. Biomacromolecules 2008;9:278–85
  • Wadell C, Björk E, Camber O. Nasal drug delivery – evaluation of an in vitro model using porcine nasal mucosa. Eur J Pharm Biopharm 1998;7:197–206
  • Di Colo G, Zambito Y, Zaino E. Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues. J Pharm Sci 2008;97:1652–80
  • Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 2001;53:3–22
  • Sommer JU, Gross S, Hörmann K, Stuck BA. Time-dependent changes in nasal ciliary beat frequency. Eur Arch Otorhinolaryngol 2010;267:1383--7
  • Jorissen M, Willems T, De Boeck K. Duagnostic evaluation of mucociliary transport: from symptoms to coordinated ciliary activity after ciliogenesis in culture. Am J Rhinol 2000;14:345–52
  • Hoyer H, Schlocker W, Kafedjiiski K. Preparation and evaluation of microparticles from thiolated polymers via jet milling. Eur J Pharm Biopharm 2008;69:476–85
  • Dimova S, Mugabowindekwe R, Willems T, et al. Safety-assestment of 3-methoxyquercetin as an antirhinovial compound for nasal application: effect on ciliary beat frequency. Int J Pharm 2003;263:95–103

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.